Health Aid for Knee Osteoarthritis
KOA-HAID
A Randomized Controlled Trial of a Health Aids for Knee Osteoarthritis
1 other identifier
interventional
159
1 country
1
Brief Summary
Knee osteoarthritis is a common condition that can cause pain, stiffness, and difficulty with daily activities. Many patients interpret these symptoms as signs of ongoing joint damage, which can influence their expectations and decisions about treatment. This randomized controlled trial compares three approaches used during a routine orthopedic visit: a health aid, a decision aid, and usual care. The health aid is designed to improve patients' understanding of knee osteoarthritis by addressing common misconceptions and helping patients develop a more accurate and less distressing understanding of their condition. The decision aid provides structured information about treatment options. In the usual care group, patients receive standard clinical consultation without additional educational materials. The main goal of the study is to evaluate differences in patients' understanding of knee osteoarthritis immediately after the clinic visit. Secondary outcomes include patients' interest in additional care options such as imaging, physical therapy, injections, and surgery, as well as measures of trust in the clinician and care experience. The results of this study may help improve how information is communicated to patients with knee osteoarthritis and guide future approaches to patient education and shared decision-making.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable knee-osteoarthritis
Started Jul 2026
Shorter than P25 for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 21, 2026
CompletedFirst Posted
Study publicly available on registry
June 25, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
June 25, 2026
June 1, 2026
6 months
June 21, 2026
June 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-visit misconception score
Difference in post-visit misconception scores among patients with knee osteoarthritis randomized to a health aid, decision aid, or usual care group. Scores range from 0 to 16, with higher scores indicating a more accurate understanding of knee osteoarthritis.
Measured once, immediately following consultation with the musculoskeletal specialist
Secondary Outcomes (6)
Interest in return visit
Measured once, immediately following consultation with the musculoskeletal specialist
Interest in an imaging test
Measured once, immediately following consultation with the musculoskeletal specialist
Interest in physical therapy referral
Measured once, immediately following consultation with the musculoskeletal specialist
Interest in steroid injection
Measured once, immediately following consultation with the musculoskeletal specialist
Interest in surgery
Immediately after the clinic visit
- +1 more secondary outcomes
Study Arms (3)
Usual Care (Control)
NO INTERVENTIONStandard clinical visit without additional educational material
Health Aid
OTHERPatients review a health aid addressing misconceptions about knee osteoarthritis during the visit
Decision Aid
OTHERPatients review a decision aid describing treatment options for knee osteoarthritis during the visit
Interventions
Patients review a health aid addressing misconceptions about knee osteoarthritis during the visit
Patients review a decision aid describing treatment options for knee osteoarthritis during the visit
Eligibility Criteria
You may qualify if:
- New patient seeking musculoskeletal specialty care
- English literacy
- Aged 18-89 years
- Diagnosed with knee osteoarthritis
You may not qualify if:
- Cognitive or physical impairment precluding tablet use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- David Ringlead
Study Sites (1)
University of Texas At Austin
Austin, Texas, 78712, United States
Related Publications (2)
Wilkens SC, Ring D, Teunis T, Lee SP, Chen NC. Decision Aid for Trapeziometacarpal Arthritis: A Randomized Controlled Trial. J Hand Surg Am. 2019 Mar;44(3):247.e1-247.e9. doi: 10.1016/j.jhsa.2018.06.004. Epub 2018 Jul 18.
PMID: 30031600BACKGROUNDKleiss IIM, Kortlever JTP, Ring D, Vagner GA, Reichel LM. A Randomized Controlled Trial of Decision Aids for Upper-Extremity Conditions. J Hand Surg Am. 2021 Apr;46(4):338.e1-338.e15. doi: 10.1016/j.jhsa.2020.09.003. Epub 2020 Nov 6.
PMID: 33162270BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Ring, MD, PhD
University of Texas at Austin
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor and Associate Chair for Faculty Academic Affairs Department of Surgery and Perioperative Care Courtesy Professor of Psychiatry and Behavioral Sciences
Study Record Dates
First Submitted
June 21, 2026
First Posted
June 25, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
June 25, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared with other researchers. The study involves patient-reported outcomes collected during clinical encounters, including measures of health perceptions, treatment preferences, and trust. Due to the sensitive nature of these data and the absence of a predefined data-sharing infrastructure or funding mandate for data deposition, individual participant data will not be made publicly available. Aggregate study findings will be reported in peer-reviewed publications.